LifeLine

Covid-19: Study shows Remdesivir effective in monkeys

By Kemo Cham

An experimental drug, Remdesivir, is reported to have shown effectiveness against Covid-19, raising hopes of a cure for the viral pandemic.

The antiviral drug, which was developed by Gilead Sciences, is one of nearly 200 experimental drugs on trial. It is under study in a small experiment by US government scientists.

The trial involves monkeys.

The scientists reported last Friday it causes the virus to add mutations that can destroy it.

Eradication of sickle cell is possible – says Nigerian geneticist

By Kemo Cham

A Nigerian scientist, Professor Cyril Otoikhian, has vowed that the medical condition Sickle Cell can be eradicated through awareness raising.

Prof. Otoikhian, who is on a mission to dismantle a long held conception that the condition is an African disease, is using Sierra Leone to realize this daunting task with a campaign through his Foundation.

Health stories of the week

By Kemo Cham

Research shows BCG vaccine can be more protective

BSG, the vaccine used to prevent against Tuberculosis (TB), has for long been ineffective, but a new research has shown that its effectiveness can be improved upon.

Scientists at the University of Pittsburgh in the United States say they have found that the mode of administering the vaccine increases its effectiveness.

Masanga Lassa Fever incident: A crucial test for Sierra Leone’s emergency preparedness

By Kemo Cham

Imagine this: A pregnant woman is operated on by a team of surgeons. Immediately after the surgery she bled to death.

Shortly after, on the same day, a second patient battling for her life after an illegal abortion procedure went wrong, is brought in, operated on by the same team of doctors in the same theater, and she later bled to death.

The doctors treated the two cases as pregnancy related deaths. Case closed!

If this was a simulation, this particular team of doctors clearly failed the test.

Sierra Leone: Finally Ebola vaccine is here

By Kemo Cham

After more than two decades of waiting, the world has finally got a vaccine for the deadly Ebola Virus Disease (EVD).

The European Commission granted marketing authorization to Ervebo, the vaccine created by the pharmaceutical giant, Merck, last Monday. A day later, the World Health Organization (WHO) also announced its pre-qualification approval.

Ervebo also got a node from the European Medicines Agency last month.

Pages

Top